GI
ETNB

GAMMA Investing’s 89bio ETNB Stock Holding History

GAMMA Investing’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-795
Closed -$11.7K – 4089
2025
Q3 		$11.7K Sell
795
-26
-3% -$265 ﹤0.01% 2803
2025
Q2 		$8.06K Sell
821
-231
-22% -$1.91K ﹤0.01% 2914
2025
Q1 		$7.65K Buy
1,052
+899
+588% +$7.86K ﹤0.01% 2877
2024
Q4 		$1.2K Buy
153
+43
+39% +$354 ﹤0.01% 3371
2024
Q3 		$814 Buy
110
+98
+817% +$824 ﹤0.01% 3304
2024
Q2 		$96 Sell
12
-154
-93% -$1.38K ﹤0.01% 3407
2024
Q1 		$1.93K Buy
166
+138
+493% +$1.53K ﹤0.01% 2755
2023
Q4 		$277 Buy
+28
New +$257 ﹤0.01% 3090

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's ETNB Position: Q4 2025 in Review

GAMMA Investing sold out of 89bio (ETNB) in Q4 2025, closing a stake of 795 shares — an estimated $11.7K sold.

GAMMA Investing first reported a position in ETNB in Q4 2023 and held it in 8 quarters. The position peaked at $11.7K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • GAMMA Investing reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • GAMMA Investing sold 795 89bio shares in Q4 2025, an estimated $11.7K.
  • GAMMA Investing first reported a position in 89bio in Q4 2023 and held it in 8 quarters.
  • GAMMA Investing's 89bio position peaked at $11.7K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.